Metraipolis › archive › dc_4890e177e4bf

Effectiveness of oral semaglutide versus empagliflozin for the management of type 2 diabetes. PIONEER-2 trial emulation with real-world data — Europe PMC PMID:40990044

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40990044
DOI
10.1111/dom.70151
License (as archived)
solo-consultazione
Archived
2026-11-09T19:23:22.410Z
SHA-256 of the archived text
d327458c3c82cd7e8fa864c74a47dcf35165d19e7f7bd16c1657dc3b02f8171b
Stable URL of this page
https://metraipolis.com/documento/dc_4890e177e4bf

How to cite

Effectiveness of oral semaglutide versus empagliflozin for the management of type 2 diabetes. PIONEER-2 trial emulation with real-world data — Europe PMC PMID:40990044 — Europe PMC (en), https://europepmc.org/article/MED/40990044 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4890e177e4bf (Metraipolis archive dc_4890e177e4bf, sha256 d327458c3c82cd7e8fa864c74a47dcf35165d19e7f7bd16c1657dc3b02f8171b)
BibTeX
@misc{dc4890e177e4bf,
  title = {Effectiveness of oral semaglutide versus empagliflozin for the management of type 2 diabetes. PIONEER-2 trial emulation with real-world data — Europe PMC PMID:40990044},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40990044},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4890e177e4bf; sha256 d327458c3c82cd7e8fa864c74a47dcf35165d19e7f7bd16c1657dc3b02f8171b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40990044. Agents can read the archived copy with the MCP tool read_document.